Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Neurologic complications in patients with inflammatory bowel disease: Increasing relevance in the era of biologics.
Relationship between Sustained Disability Progression and Functional System Scores in Relapsing-Remitting Multiple Sclerosis: Analysis of Placebo Data from Four Randomized Clinical Trials.
Discovery of peptoid ligands for anti-aquaporin 4 antibodies.
Importance of Rookshana Karma (dehydrating therapy) in the management of transverse myelitis.
Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden.
Presymptomatic diagnosis with MRI and adequate treatment ameliorate the outcome after natalizumab-associated progressive multifocal leukoencephalopathy.
A genome-wide association study in progressive multiple sclerosis.
Granzyme B-Induced Neurotoxicity Is Mediated via Activation of PAR-1 Receptor and Kv1.3 Channel.
Riluzole blocks persistent Na+ and Ca2+ currents and modulates release of glutamate via presynaptic NMDA receptors on neonatal rat hypoglossal motoneurons in vitro.
1,25-Dihydroxyvitamin D3 Facilitates M2 Polarization and Upregulates TLR10 Expression on Human Microglial Cells.
Predictors of disease activity in 857 patients with MS treated with interferon beta-1b.
Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes.
Quality of life in the care home: a qualitative study of the perspectives of residents with multiple sclerosis.
Network analysis of transcriptional regulation in response to intramuscular interferon-β-1a multiple sclerosis treatment.
Cryptococcal meningitis in a multiple sclerosis patient taking natalizumab.
Report of Three Cases of Herpes Zoster During Treatment with Natalizumab.
Conditional DC depletion does not affect priming of encephalitogenic Th cells in EAE.
The potential for new therapeutic approaches: Global research collaboration examines multiple pathways of neuroprotection in Huntington disease
No excess of mitochondrial DNA deletions within muscle in progressive multiple sclerosis.
Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.
Innovation at RUSH
Severe septal panniculitis in a multiple sclerosis patient treated with interferon-beta.
Comorbid Multiple Sclerosis and TDP-43 Proteinopathy in a Gulf War Sea Captain.
Minocycline in Clinically Isolated Syndromes (CIS) and Early Single Relapse Multiple Sclerosis (MS)
Safety and efficacy extension study of daclizumab high yield process (DAC HYP) to treat relapsing remitting multiple sclerosis

Pages